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New insights about the monomer and homodimer
structures of the human AOX1†
P. Ferreira, a N. M. F. S. A. Cerqueira, a C. Coelho,b P. A. Fernandes, a
M. J. Roma˜ob and M. J. Ramos *a
Human aldehyde oxidase (hAOX1) is a molybdenum dependent enzyme that plays an important role in
the metabolism of various compounds either endogenous or xenobiotics. Due to its promiscuity, hAOX1
plays a major role in the pharmacokinetics of many drugs and therefore has gathered a lot of attention
from the scientific community and, particularly, from the pharmaceutical industry. In this work,
homology modelling, molecular docking and molecular dynamics simulations were used to study the
structure of the monomer and dimer of human AOX. The results with the monomer of hAOX1 allowed
to shed some light on the role played by thioridazine and two malonate ions that are co-crystalized in
the recent X-ray structure of hAOX1. The results show that these molecules endorse several
conformational rearrangements in the binding pocket of the enzyme and these changes have an impact
in the active site topology as well as in the stability of the substrate (phthalazine). The results show that
the presence of both molecules open two gates located at the entrance of the binding pocket, from
which results the flooding of the active site. They also endorse several modifications in the shape of the
binding pocket (namely the position of Lys893) that, together with the presence of the solvent
molecules, favour the release of the substrate to the solvent. Further insights were also obtained with
the assembled homodimer of hAOX1. The allosteric inhibitor (THI) binds closely to the region where the
dimerization of both monomers occur. These findings suggest that THI can interfere with protein
dimerization.
1. Introduction
The metabolism of xenobiotics is a critical aspect of drug
discovery.1 In the last decades, massive investments have been
made toward this research area, which enabled the development
of new and more efficient in silico and in vitro screening systems.
This led to a small (10%) but still important increase in the
number of compounds that reach the final stages of the drug
development pipeline. Although these investments started to
pay off the initial investments, they are still insufficient to
make drug discovery efficient. This happens mainly because
the metabolism of these compounds is very complex and can
invoke multiple enzymes.1
Along with the well-studied endoplasmic cytochrome P450
system (CYP450), the cytosolic aldehyde oxidase (AOX) has
recently emerged as a new key metabolic enzyme in the hepatic
phase I metabolism of numerous xenobiotics and in the
activation of several prodrugs.2–5 However, while the mecha-
nism of action of CYP450 has been intensively studied, the one
played by AOX remains poorly understood. This occurs due to
the lack of experimental data regarding this enzyme, and that
only now starts to become available. An example of this fact is
the X-ray structure of the human AOX (hAOX1, EC 1.2.3.1) that has
only been characterized very recently by X-ray crystallography.6
The available X-ray structure of hAOX1 shows a monomer
that is composed by three subdomains: a 20 kDa N-terminal
domain containing the two Fe2S2 clusters, a 40 kDa central
FAD-containing domain and an 85 kDa C-terminal domain
containing the Moco.6
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Recent studies have also shown that hAOX1 has a broad
substrate affinity and catalyses not only the oxidation of
aldehydes and the hydroxylation of heterocycles but also
reduction reactions of nitro compounds and N- and
S-oxides.2,5 The substrates differ substantially from the ones
that are catalysed by CYP450, but still little is known on which
substrates are specific for each enzyme. It is therefore very
difficult to predict when AOX or CYP450 are responsible for the
failures of specific clinical candidates.
Taking into account what has been described, new develop-
ments regarding hAOX1 are urgent and of great interest. Since
only little experimental data regarding hAOX1 is available,
computational methods can be used to unveil important
features at the atomic level that can help to shed some light
on the structure of this enzyme. The insights that computa-
tional approaches can provide are very important to comple-
ment the available experimental information and to overcome
some limitations that constrain those experiments.
In this article, molecular dynamics simulations (MD) were
carried out to provide a comprehensive study on the behaviour
of hAOX1 over time, and from which significant insights
regarding important structural features of the protein will be
analysed. In addition, it was also studied the impact that the
allosteric inhibitor thioridazine (THI) and the malonate ions
(MLI) have in the behaviour of the enzyme. These compounds
are found in specific regions of the co-crystallized X-ray
structure of the hAOX1 and, while the inhibitor THI was found
in an unexpected groove at the protein surface, no information
about the putative role of MLI was provided.6 The presence of
malonate ions is essential for protein crystallization. The other
co-crystallized ligands in the X-ray structure are the molybdenum
cofactor (Moco) and the substrate phthalazine (PHT) involved in
the catalytic reaction of the enzyme, and the FAD and two iron–
sulfur (Fe2S2) clusters involved in the transfer of electrons between
the Moco and the FAD molecule.
As the active form of hAOX1 is a homodimer,7 protein–
protein docking together with long MD simulations were also
performed to analyse the homodimer complex and study the
effect of thioridazine in the dimerization process.
2. Methodology
2.1. Modelling
The crystallographic structures of the hAOX1 available in the
protein databank (PDB: 4UHX; 4UHW)6 are not complete, the
coordinates of some residues located on the protein surface,
namely resides 167 to 199, 570 to 571, 655 to 660, 713 to
715 and 881 to 882) are missing. In this work, the PDB structure
of 4UHX was used since it contains all the ligands (THI, MLI
and PHT) whose impact on the protein structure was evaluated.
In order to complete the three-dimensional structure of this
enzyme, modelling techniques were applied. The modelling
was conducted using the SWISS-MODEL8–11 modelling server.
From all the models that were generated, the one that provided
the best Global Model Quality Estimation (GMQE) and QMEAN
scores9 was selected for further analysis and used in the molecular
dynamics simulations. The values of the GMQE and QMEAN
scores of the selected structure were 0.98 and 1.25 respectively.
2.2. Parametrization of Moco, thioridazine and malonate
ions.
One of the major limitations when studying metalloproteins,
using computational approaches, is the lack of force field
parameters of the cofactors. This work is no exception and we
had to parameterize all the force constants and equilibrium
values for all the bonds and angles involving the Mo ion as well
as the charges of the Moco. Initially, the geometry of the Moco
was optimized using density functional theory (DFT) calcula-
tions and then, potential energy surface scans were conducted
in all bonds and angles involving Mo. The determination of the
force-field parameters was based on a semi-flexible model
approach. This means that the position of some atoms were
frozen during the calculations in order to prevent unrealistic
fluctuations of the coordination sphere and, thus, to mimic the
conformation the cofactor adopts inside the protein.
In the proposed scheme, bond and angle parameters were
determined from linear transit scans along the internal coordi-
nates associated with metal–ligand interactions. Electrostatic
charges were determined from a RESP fitting of Merz–Kollman
charges. The atomic charges were calculated from the opti-
mized structure, at the B3LYP/SDD:6-311++G(3df,2pd) level of
theory. More details about the methodology of the development
and testing of the parameters can be found in our article.12
The force field parameters of the substrate (phthalazine –
PHT), the allosteric inhibitor (thioridazine – THI), malonate
ions (MLI) and the FAD were parameterized using the ANTE-
CHAMBER module13 of the AMBER12 package.14 The para-
meters of the Fe2S2 clusters (FES) were taken from the
literature.15 The THI molecule was parameterized in its neutral
form, even though its pKa in aqueous solution is reported to be
9.5,16 because, as it can be observed in the X-ray structure, it
sits in a hydrophobic pocket. Additionally, it can be seen that
several hydrogen bond acceptors are present around the nitrogen
atom of the methyl piperidine ring and free to reorient. However,
not even one orients itself towards the piperidinic nitrogen,
indicating that the thioridazine binds the active site cavity mostly
in the neutral form.
The resulting frcmod and prep/lib files are transcribed in
the ESI.† The parameters of the Moco are shown in Table SI-2
(ESI†). The behaviour of all ligands whose parameters were
either adapted from existing force fields (THI, MLI, PHT and
FAD) or from the literature (FES), or were determined by us
(Moco) was carefully examined to assure they maintained a
coherent structure throughout the simulations, we also calcu-
lated the mean RMSd of all ligands (Table SI-1, ESI†) which
returned small values reinforcing our confidence in the
adopted parameters.
All calculations were carried out with the B3LYP/SDD:
6-31G(d) level of theory using the Gaussian09 package.17
B3LYP18–20 is currently the most used functional, yielding good
results on the estimate of several thermodynamic parameters
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and the use of the effective core potentials (ECPs) is a common
feature in the optimization of systems with transition metals.
The SDD21,22 pseudopotential implemented in the Gaussian
software, has been widely used in several studies.23–25
2.2.1. Molecular dynamics protocol. The x-leap module of
AMBER12 was used to protonate the complex, assuming that all
residues were in their physiological protonation states, and
13 Na+ counter-ions were added to neutralize the charge of the
system. Additionally, the system was surrounded with water
molecules using a truncated rectangular box of TIP3P water
molecules with a minimum distance of 12 Å between any atom
of the protein and the faces of the box. The ff10 force field and
the general Amber force field (GAFF)26 were used to describe
the protein, MLI, THI, PHT and FAD. The total number of
atoms in the system (including waters) varied (according to the
number of ligands included in each model) between 143 819 in
model 1 and 150 564 in model 2.
Before the MD simulations, four step minimizations cycles,
using the steepest descent algorithm, were carried out to
remove eventual tensions or clashes in the structure. In the
first step, the water molecules added by x-leap were minimized,
in the second step, the hydrogen atoms were minimized, in the
third step, the side chains of the protein were minimized and,
finally, in the fourth step, all the system was minimized.
After the minimization procedure, the MD simulation pro-
tocol was conducted. Starting from the structure obtained after
the minimization procedure, the system was gradually warmed
to 310.15 K, under constant volume periodic boundary condi-
tions (NVT), using the Langevin thermostat for that purpose, in
a 20 picoseconds long equilibration step. Then, a 300 nanose-
conds long production step was conducted under constant
pressure and temperature (NPT) using the Langevin thermostat
and the Berendsen barostat for that purpose. The cut-off for the
Lennard-Jones interactions was set to 10 Å. The Coulomb
interactions were treated using the Particle Mesh–Ewald
(PME) method, with a cut-off of 10 Å for the real part of the
sum. The time step of numerical integration was 2 fs. This
protocol was conducted in three replicates for each model.
Thus, the total simulation time for each model was 900 ns.
The trajectories obtained with the MD simulations were visua-
lized using VMD.27 The numerical results of the simulations were
interpreted using the cpptraj program in the AMBER 12 package.
2.3 Protein–protein docking protocol
In order to generate the homodimer complex of hAOX1, protein::
protein docking calculations, using the ClusPro 2.0 webserver,28–31
were carried out.
The ClusPro2.0 performs a rigid-body docking using a
PIPER-based algorithm, a docking program based on the Fast
Fourier Transform (FFT) correlation approach that has per-
formed well in the CAPRI (Critical Assessment of Prediction of
Interactions) docking challenge and in other docking bench-
marks. We used the ‘‘balanced’’ energy function coefficients as
described in ref. 31. The number of solutions of each cluster,
together with the visual analysis of the resulting complexes, was
chosen as criteria to select the final dimer model.
To analyse the robustness of the homodimer, a MD simula-
tion of 50 ns was performed using the protocol that was
described in the previous sections.
3. Results and discussion
Despite the key role played by AOX in human metabolism only
fragmentary information about the enzyme is available. The
recent X-ray structure of hAOX1 homodimer6 (crystallographic
symmetry) revealed the position of all the four prosthetic
groups: one Moco cofactor, two Fe2S2 clusters and one FAD
molecule, as well as one of the substrates of the enzyme,
phthalazine (PHT), which is located very close to Moco. In the
deposited structure, two additional molecules are identified:
the non-competitive inhibitor thioridazine (THI) that becomes
lodged in a particular region at the protein surface and two
malonate ions (MLI) that are used as crystallization additive.
The two MLI are located nearby the Fe2S2 cofactors.
In order to shed some light on the role played by these
molecules in the enzyme and the impact that they have in the
protein structure, several models of the hAOX1 monomer were
created containing different combinations (presence/absence) of
THI, MLI and PHT. These results will be presented in the first sub-
section of the discussion section, where several MD simulations
and structural analyses were carried out. Subsequently, we will
discuss the assemblage of the dimer of hAOX1 using protein::
protein docking methodologies that were followed by a 50 ns long
MD simulation. These results allowed to provide additional details
about the role played by THI and the amino acid residues that are
important for the dimerization process.
3.1. Computational insights regarding the hAOX1 monomer
Both X-ray structures deposited in the protein data bank (PDB
code: 4UHX and 4UHW) lack the coordinates of some amino
acid residues that correspond to exposed mobile regions. To
complete these gaps, modelling techniques were used to pro-
duce an integral structural model of the monomer of hAOX1.
From the resulting model, six different complexes were
generated, regarding the presence/absence of substrate (PHT),
malonate ions (MLI) and the allosteric inhibitor (THI), as
illustrated in Fig. 1. Each of those models was subjected to
three replicates of 300 ns long molecular dynamics simulation
and thereby used to obtain important functional information.
The different analyses made to these structures are discussed in
the next sections.
3.1.1. Global analysis of the MD simulations. The root
mean square deviation (RMSd) plots determined from all the
MD simulations are displayed in Fig. 2. These plots show that,
after the first 10 ns, all models were equilibrated. In the
following frames (290 ns), the overall structure of the crystallo-
graphic residues remained almost constant and exhibited an
overall RMSd value between 2.68 and 2.98 Å. Most of the
structural fluctuations on the protein structure came from the
very mobile loop (residues 167–199) that was modelled (Fig. 2),
as well as from the binding pocket where some conformation
PCCP Paper
Pu
bl
ish
ed
 o
n 
03
 Ju
ne
 2
01
9.
 D
ow
nl
oa
de
d 
by
 K
EA
N
 U
N
IV
ER
SI
TY
 o
n 
7/
30
/2
01
9 
8:
09
:0
8 
A
M
. 
View Article Online
13548 | Phys. Chem. Chem. Phys., 2019, 21, 13545--13554 This journal is© the Owner Societies 2019
rearrangements are observed. The overall RMSd values after the
first 50 ns range between 2.73 and 3.03 Å. Although there is a
small increase in the mean values comparatively to those
obtained from 10 ns to the end, they stay within standard
deviation values indicating that the overall structure remains
stable.
The mean RMSd values with the contribution of the
modelled residues taken into account stayed between 3.61
and 4.16 Å (after 10 ns) and between 3.63 and 4.32 Å (after
50 ns) (see Table 1). Although these values are not small, they
are acceptable for regions that do not have a defined secondary
structure and are very exposed to the solvent, as it happens to
be the case.
The conformational rearrangements in the binding pocket have
a lower contribution to the total RMSd values and result from the
absence of some molecules that were initially present in the X-ray
structure of hAOX1 (used to build all the models). These differ-
ences are those that we were seeking since they will tell us the
impact that each molecule has in the protein structure.
The behaviour of the Moco was carefully examined in all the
MD simulations to ensure that all the parameters adopted were
reliable and did not introduce any instability into the system.
The RMSd of the Moco remained below 1.0 Å in all models
throughout the full simulation in all replicates (Table 1), con-
firming that the determined parameters are robust and reliable. As
expected, despite these small conformational rearrangements in
the Moco cofactor, when it is superimposed to the X-ray structure
of hAOX1, it occupies the same region of the active site and only a
small translation is observed.
Similar conclusions can also be drawn analysing the root
mean square fluctuations (RMSF) of all the residues present in
eachmodel. As expected, themajority of the residues that exhibited
high fluctuations belong to the 32 AA exposed region that was
modelled, comprising the residues 167 to 199 as it is clearly seen in
Fig. 3. Some fluctuations are also found around the entrance of the
binding pocket and in solvent exposed areas of the enzyme. This is
clear in the RMSF values of the residues from 1120 to 1170.
3.1.2. Distribution of the water molecules in the binding
pocket of hAOX1. The distribution of the water molecules in the
binding pocket of hAOX1 was also evaluated in all models. This
was achieved through the calculation of the radial distribution
function (RDF) near the Moco.
Fig. 1 (A) 3D representation of the X-ray structure of hAOX1 (monomer) and relative positions of all the ligands present in the crystallographic structure.
In the 3D structure the blue colored domain represent the 85 kDa C-terminal domain containing the Moco, the dark yellow colored domain represent
the 20 kDa N-terminal domain containing the two Fe2S2 clusters and the red colored domain represent the 40 kDa central FAD-containing domain. (B)
Schematic representation of the composition of the six models of hAOX1 that were created. The FAD, the Fe2S2 clusters and the Moco were present in all
models. 2D structures of all ligands are available as ESI,† (Fig. SI-1). MLI = malonate ion; PHT = phthalazine; THI = thioridazine.
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In all models, the RDF analysis shows that only a few water
molecules can be found near the Moco. This occurs due to the
hydrophobic nature of the binding pocket that does not allow
the concentration of many water molecules in that region of the
protein (Fig. 4). But even those that are able to penetrate into
the binding pocket, do not stay for a long time, as suggested by
the analysis of the MD trajectories and corroborated by the low
RDF values (always below 0.6, Fig. 4A). A different pattern is
observed above 4 Å from the Moco. For example, in the models
that do not contain PHT or those that contain PHT together
with THI or MLI or both, at the end of the MD simulation,
the binding pocket is soaked with water molecules above the
Moco region. In model 5, that only contains the substrate, the
binding pocket is more shielded from water molecules.
The reason behind this behaviour can be found by looking
at models 2 and 5 that include the substrate (PHT) and only
differ in the presence or absence of the MLI and THI molecules.
In these models, it can be identified the presence of two loops
near the entrance of the active site that were proposed by the
crystallographers6 to behave as two gates (Gate 1: 652 to 661
and Gate 2: 708 to 719) that control the access of substrate/
solvent and release of product to or from the binding pocket.
Loop regions that behave as gates for the access and release of
substrates, products, inhibitors and solvent at the entrance
of the catalytic tunnel are also found in other molybdenum
containing enzymes.6
In the models that contain THI and MLI (for example model
2, (Fig. 4A) these two gates adopt an open configuration that
make the binding pocket more permeable to the entrance of
water molecules (GIF-1.SI, ESI†).
In model 5, the two gates adopt a closed configuration
blocking the access of the solvent molecules to the binding
pocket (Fig. 4B) and contributing to a tighter catalytic tunnel.
This closed configuration was only observed, throughout the
simulation, in model 5. In the gif file available as ESI,†
which compares the behaviour of important of three loops of
the catalytic tunnel in model 2 (loops in red) and model 5
(loops in blue) at the beginning of the MD simulation, a
different behaviour of the two gates in model 2 and in model
5 (GIF-1.SI, ESI†) can be clearly seen. These findings are
interesting because model 5 includes only the natural substrate
of the enzyme (PHT) and should mimic the wild type enzyme.
The obtained results go therefore in line with the available
experimental data, which shows that the substrates of hAOX1
are very hydrophobic and planar and only a hydrophobic
active site with few water molecules can sustain those types
of substrates close to Moco.
Comparing the RDF results of models 1 and 6, being the
difference between the two the presence of MLI and THI in
model 6, we can conclude that the presence of the ligands in
model 6 made the active site even more permeable to water
molecules (Fig. 4A). The reason why the catalytic tunnel of
model 1 is permeable in the first place is due to the absence
of substrate, which is clear by comparing the RDF results of
models 1 and 5 (Fig. 4A).
3.1.3 Integrity of the binding pocket of hAOX1. The analysis
of the MD simulations also show that the integrity of the catalytic
tunnel is one of the ways through which THI and MLI affect the
Fig. 2 Representation of the mean RMSd values SEM of the three 300 ns
long MD simulation replicates conducted for the Models 1 to 6, of the whole
protein (black line) and of the protein without accounting the residues of the
modelled mobile loop (indigo line). To facilitate the analysis of the charts, the
ligands present in each model are indicated. The standard error of the mean is
represented as a gray area above and below the lines.
Table 1 Mean of the root mean square deviation (RMSd) values from the
10 ns and from 50 ns until the end (300 ns) of each MD simulation
replicate, obtained from each model of the protein, with and without the
unstructured region (loop that was modelled by homology modelling
(residues 167–199))
Model
RMSd (Å)
Protein with loop Protein without loop Moco
1 3.61  0.21a 2.68  0.11a 0.75  0.08a
3.63  0.18b 2.73  0.10b 0.71  0.08b
2 3.94  0.14a 2.85  0.15a 0.84  0.06a
3.94  0.13b 2.93  0.12b 0.84  0.07b
3 4.16  0.26a 2.75  0.08a 0.86  0.10a
4.32  0.11b 2.78  0.08b 0.88  0.11b
4 3.82  0.32a 2.89  0.17a 0.77  0.11a
4.01  0.20b 2.99  0.11b 0.72  0.07b
5 4.16  0.25a 2.98  0.12a 0.85  0.07a
4.28  0.15b 3.03  0.10b 0.84  0.08b
6 3.99  0.24a 2.79  0.12a 0.91  0.10a
4.11  0.10b 2.86  0.09b 0.92  0.10b
a Mean value calculated after the 10 ns mark. b Mean value calculated
after the 50 ns mark.
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normal function of hAOX1. To analyse this aspect, the position
and conformation of the residues that compose the walls of the
binding pocket were analysed. The catalytic tunnel of hAOX is
essentially composed by hydrophobic residues, namely Phe635,
Leu812, Val811, Ala919, Phe920, Phe807, Phe923, Ile1085, Phe777,
Phe885, Leu884 and Leu880. The polar and charged residues in
the walls of the tunnel are essentially found near the Moco or near
the entrance of the pocket Fig. SI-2 (ESI†).
The results show that the average position and rearrange-
ment of these residues differ from model to model. However,
there is a constant pattern among them, depending whether
the THI or MLI molecules are present or not. In the models that
contain the THI and MLI molecules, the binding pocket
becomes wider (Fig. 5, model 2; Fig. SI3, ESI†) and, similarly
to what was found in the RDFs analysis, the two gates that are
located at the entrance of the binding pocket adopt an open
conformation. This open configuration, exposes the binding
pocket to the solvent, the catalytic tunnel becomes wider which
induces the displacement of the substrate away from the
catalytic site. In model 5, the gates are closed, the solvent does
not have access to the active site and the binding pocket near
the Moco adopts a narrower conformation that maintains the
substrate close to the metallic cofactor (see gif file submitted as
ESI,† for a structural comparison of the gates in model 2 and in
model 5 in the beginning of the MD simulation).
It is worth mentioning that although THI and MLI are not
close to the region of the binding pocket (they are 31 Å and 28 Å
away from the Moco, respectively), they induce conformational
rearrangements in the structure of the protein that affect this
region. This is visible in the loops comprising the residues 791
to 815 and 913 to 924 that are close to the active site and
modulate the shape of the binding pocket. In the models that
contain the THI and MLI molecules (such as model 2) these
loops are displaced and turn the binding pocket wider than, for
example, what is observed in model 5 that does not contain THI
or MLI (only contains the substrate PHT). In this case, the
binding pocket also becomes more constrained near the Moco
region turning it more suited to bind the substrate.
The MD simulations have also shown that the modifications
endorsed by the MLI and THI molecules in the binding
Fig. 3 (A) Representation of the mean RMSF values per residue of the three MD simulation replicates for all models (1 to 6) taken in 0.2 ns intervals.
Standard deviation bars are not shown in the charts for easier viewing. To facilitate the analysis of the charts, the ligands present in each model are shown.
(B) 3D representation of models 2 and 5, highlighting the amino acid residues where the RMSF values are the highest ones.
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pocket also affect the position of the substrate PHT (Fig. SI3,
ESI†). For example, in the models that contain the substrate
with the MLI and THI or only with MLI or THI (models 2, 3 and
4 respectively), the substrate PHT dissociates from the region
nearby the Moco and becomes lodged either in the middle of
the binding pocket (10.96 Å away from the Moco (mean
distance of the three replicates) in model 4) or completely exits
from the protein (in all replicates in model 2 and in two
replicates of model 3). Only in the model 5 that does not
contain the THI and MLI molecules, the substrate stays closer
to the Moco throughout the entire simulation in all replicates
(Fig. 5). The mean distances between the Moco and the
substrate in the three replicates, over the 300 ns, are 32.89 Å
in model 2; 10.50 Å in model 3; 10.96 Å in model 4 and 6.86 Å
in model 5.
The explanation for these observations relies on the fact
that the tunnel that provides the access to the active site of
hAOX1 is very hydrophobic and, although the substrates of
hAOX1 are also hydrophobic, they contain a small polar
region that needs to be stabilized in the region near the
Fig. 4 (A) Mean RDF values of the three replicates of MD simulation of all models (1 to 6) taken in 0.2 ns intervals. To facilitate the analysis of the charts,
the molecules present in each model are indicated. The standard error of the mean is represented as a gray area above and below the lines. (B) Schematic
representation of the binding pocket of hAOX1, of models 2 and 5, indicating the loops that behave as gates (Gate 1: 652 to 661 and Gate 2: 708 to 719)
and control the access of the solvent to the binding pocket.
Fig. 5 Schematic representation of the binding pocket of hAOX1 of models 2 and 5, indicating the loops that behave as gates (Gate 1: 652 to 661 and
Gate 2: 708 to 719) and control the access of the solvent to the binding pocket, the amino acid residues that modulate the binding pocket shape and the
amino acid residues that are closer to the Moco.
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Moco (Fig. 5 and Fig. SI-2, ESI†). This region is the one that
endorses the correct orientation of the substrate inside the
binding pocket and makes it ready to react with the Moco.
Looking at the region of the binding pocket near the Moco,
there are only two amino acid residues that have such char-
acteristics and can play such role. They are Glu1270 and Lys893.
Glu1270 is inaccessible to the substrate because it lies at the
bottom of the cofactor. Lys893 is, on the other hand, rather
accessible. However, the accessibility of Lys893 to the substrate
in the binding pocket varies from model to model. In model 5,
which resembles the wild type configuration of the enzyme, this
residue is adequately accessible and interacts very closely with
the substrate PHT at the beginning of the MD simulation. In
the simulations in which the PHT dissociates from the enzyme,
the Lys893 became buried in the protein structure and unavail-
able to interact with PHT at the start of the simulation. This is
particularly evident in the models where the inhibitors THI
and MLI are present, which strongly suggests that their
presence introduces structural changes in the binding pocket
(in particular in Lys893 and Phe923) that prevent a favourable
interaction between the substrate and the active site of the
enzyme (Fig. 5).
3.2. Computational insights regarding the hAOX1
homodimer
Since hAOX1 is active as a homodimer, we also modelled
computationally the structure of the hAOX1 homodimer. To
this end, molecular docking methodologies were applied. From
these calculations, a total of 29 complexes were generated
(Fig. SI4, ESI†). From the visual analysis of all the homodimers
combined with the docking scores that were obtained, the ones
with the worst scores and unfeasible complexes were discarded.
Among the best scored ones, we analysed the contact surface
area between both monomers and the one where this value was
maximum was chosen for further analysis.
The selected structure was then subjected to a long mole-
cular dynamics simulation of 50 ns. After an initial adjustment
between both monomers, the full system stabilized after 20 ns
with an RMSd around 4 Å (Fig. 6A). The full stabilization of the
dimer interface was however only obtained after 30 ns as it can
be seen through the analysis of the area of contact between
both monomers during the full MD simulation (which was
calculated using the Volarea plugin32 for VMD, Fig. 6B).
The stabilized structure of the hAOX1 homodimer revealed
that both monomers bind in an almost symmetrical way and a
perfect contact between both surfaces was obtained.
Another interesting information that can be obtained from
the hAOX1 homodimer complex concerns the location of THI.
By superimposing the X-ray structure of hAOX1 with the
generated homodimer, it becomes clear that THI binds very
closely to the dimerization region (Fig. 7). This means that THI
can interfere with the dimerization of the enzyme, and there-
fore besides interfering with the structure of the binding pocket
(discussed before), it may also influence the formation of an
active hAOX1.
4. Conclusions
In this work, homology modelling, molecular docking and MD
simulations were used to gather a detailed atomistic analysis of
the monomer and homodimer of hAOX1. With these studies,
we were able to investigate the impact that the substrate, the
MLI ions and the allosteric inhibitor THI have in the dynamics
of the enzyme.
The performed analysis allowed concluding that the THI
and MLI molecules interfere with the structure of the enzyme,
with emphasis in the region of the binding pocket. Although
these two molecules are far away from this region of the
protein, they endorse specific modifications in some loops of
the protein, in particular loops 791–815 and 913–924 that are
close to the binding pocket. These readjustments influence the
Fig. 6 Representation of the RMSd of the backbone of the hAOX1
homodimer (A) and the surface area of contact between both monomers
(B) during the full MD simulation.
Fig. 7 Structure of the hAOX1 homodimer with the position of the
allosteric inhibitor THI highlighted in red.
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configuration of other two loops that are located at the entrance
of the binding pocket and behave as gates (Gate 1: 652 to 661
and Gate 2: 708 to 719) that control the entrance of the solvent
and possibly the substrate. In the models that contain THI and
MLI, these gates adopt an open configuration and the binding
pocked becomes more permeable to water molecules. When
only the substrate is present, the gates adopt a close configu-
ration and the metallic cofactor becomes more shielded from
water molecules.
The presence of THI and MLI species also reshape the region
of the binding pocket that is close to the Moco. In particular,
they turn the region near the Moco wider and Lys893 remains
buried in the protein surface. When this happens, the substrate
no longer interacts efficiently with the Moco and tends to
dissociate to the solvent. This result highlights the importance
of Lys893 in the active site, which plays an important role in
stabilizing the substrate and turn it ready for catalysis. Similar
conclusions were also observed in the AOX from mouse.33
The assemblage of the hAOX1 homodimer provided new and
important insights about the dimerization process that is
required for the full activity of the enzyme.
The hAOX1 homodimer has also revealed that the allosteric
inhibitor THI binds very closely to the region where contact
between the two monomers occurs. These results suggest that
in addition to the structural modification that THI makes in the
binding pocket, it can also interfere with protein dimerization.
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